Gateway Analytical Presents on Analytical Testing Methods for Inhalable Drug Products at Medicon Valley Inhalation Symposium

October 11, 2017

Gibsonia, PA – Gateway Analytical announces participation in the 6th Medicon Valley Inhalation Symposium (MVIS) in Lund, Sweden being held on October 11-12, 2017. Gateway Analytical will serve as one of the platinum sponsors for the conference, as well as participating in two scientific presentations about analytical testing services for respiratory drug products, developed in collaboration with Next Breath and Circassia.

Gateway Analytical has partnered with both Next Breath and Circassia for a presentation called “SEM-EDS and Raman Spectroscopy to Accelerate Generic Drug Applications” to be given by Dr. Oliver Croad from Circassia on Wednesday, October 11. The talk will focus on the combined approaches used for particle identification, particle size and agglomerates testing services to support regulatory expectations. Additionally, the three companies have worked together to prepare “Advancing in vitro similarity assessment for inhaled tiotropium formulations” which details how they are working together to address specific challenges in developing respiratory drug products. The presentation will be given by Dr. Julie Suman of Next Breath on Thursday, October 12.

“Gateway Analytical is pleased collaborate with Next Breath and Circassia to provide an overview of our full suite of testing services to respiratory drug developers and manufacturers,” says David Exline, President at Gateway Analytical. “Our support of the MVIC Symposium allows us to educate attendees and clients on a comprehensive range of solutions and expertise in both common and specialized areas.”

Please visit http://www.gatewayanalytical.com/ for more information on Gateway Analytical; http://www.nextbreath.net for more information on Next Breath; and http://www.circassia.com for more information on Circassia.

###

About Gateway Analytical

Gateway Analytical is the innovative analytical testing laboratory that businesses around the world trust to provide solutions for their most challenging foreign particulate analysis, foreign particulate identification and materials analysis needs. Gateway’s expert scientists, specialized testing techniques and comprehensive analysis methods allow the company to deliver the fast, accurate and reliable results that customers in the pharmaceutical, materials and medical device industries demand. To learn more about Gateway Analytical and how it is making the world healthier and safer, visit www.gatewayanalytical.com.

Gateway Analytical is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation.
 

Media Contact
Tifanie Tiberio
Marketing Manager
tiberiot@gatewayanalytical.com 
+1 724.443.1900